Westmount Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Hold |
1,000
| – | – | 0.09% | 180 |
|
|
2025
Q1 | $270K | Hold |
1,000
| – | – | 0.08% | 196 |
|
|
2024
Q4 | $235K | Hold |
1,000
| – | – | 0.07% | 192 |
|
|
2024
Q3 | $275K | Sell |
1,000
-5
| -0.5% | -$1.38K | 0.08% | 175 |
|
|
2024
Q2 | $245K | Buy |
+1,005
| New | +$245K | 0.08% | 180 |
|
|
2023
Q2 | – | Sell |
-1,000
| Closed | -$200K | – | 189 |
|
|
2023
Q1 | $200K | Hold |
1,000
| – | – | 0.09% | 172 |
|
|
2022
Q4 | $238K | Buy |
+1,000
| New | +$238K | 0.12% | 152 |
|